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later in life. 2, 3 It occurs in women 2-3 times as often in men. 4 The secundum type atrial septal defect (ASDs) is the most common with an incidence of 3.78 per 10,000 live births, 5 corresponding to 5.9% of diagnosed CHDs in children. 6 For several decades, these defects have either been repaired surgically or treated medically.
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The development of devices for transcatheter closure of ASD represents an important advance in catheterbased management of congenital heart defects. A variety of devices has been developed over the past decades. The Amplatzer septal occluder (ASO) (AGA Medical Cooperation, Golden Valley, Minnesota, USA) is a selfcentering, self-expanding double-disc device ( Fig. 1 ) made of 0.004-0.0075 Nitinol wire mesh (55% nickel and 45% titanium), effective for closing ASDs.
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Figure 1. An Amplatzer septal occluder, a double disc nitinol-wire mesh connected by a waist that corresponds to the size of the defect.
Transcatheter closure of secundum atrial septal defect (ASDs) with Amplatzer septal occluder (ASO) has been an alternative intervention to surgery. More and more patients chose this procedure due to several reasons such as no surgical scar, short duration of hospital stay which is only 2 nights. The procedure is performed in the cardiac catheterization laboratory under general anesthesia, using transesophageal echocardiography (TEE) as guidance. TEE has become a routine procedure as guidance and monitoring proper device placement during transcatheter closure of ASDs. 7, 8, [12] [13] [14] To simplify the procedure and to reduce the cost, recently we used transthoracal echocardiography (TTE) in guiding the ASO implantation in some patients. Not using general anesthesia resulted in reduced cost of 750,000 rupiahs. Aim of this study is to evaluate accuracy and performance of ASO procedure guided by TTE compared to ASO procedure guided by TEE.
METHODS
We evaluated all transcatheter closure of ASDs with ASO that have been attempted in the Cardiac Catheterization Laboratory of National Cardiovascular Center Harapan Kita, Jakarta, from September 2002 to July 2006. All procedures guided by TEE were performed under general anesthesia, while in those guided by TTE, they were fully awake, except in small children where sedatives were given. Indication of closing ASDs is the same as for surgery, inclusion criteria were single ASDs, significant left to right shunt, superior rim of at least 5 mm, the defect had to be at least 5 mm away from coronary sinus, atrio-ventricular valves, and right pulmonary vein. Exclusion criteria were multiple ASD, insufficient superior rim, pulmonary vascular disease, associated CHD requiring surgery, partial anomalous of pulmonary vein drainage, congestive heart failure with ejection fraction <30%. Selection of cases were performed in outpatient clinics with TEE; in small children, the procedures were performed in the one day care ward. Children with body weight less than 20 kg and size of defect more than 20 mm were sent to surgery.
In TTE procedure, we used transthoracal 4-chamber view to visualize the atrial septum in vertical position. When the sizing balloon was inflated for defect diameter sizing, it was in horizontal position in the atrial septum (Fig. 2) . In this view we could visualize the guiding catheter going through the defect. When the devices were in the left atrium with the left sided part deployed, the devices position were aligned with the atrial septum ( Fig. 3 ), so we were fully guided by the picture. Then we continued with deploying the right atrial disc (Fig. 4) . If from the TTE the position of the device was correctly adjusted to the defect, the device was released from the cable. Sizes of defects measured that were evaluated in this study were stretched diameters measured by TEE or TTE and fluoroscopy with balloon sizing. Data was presented in count (percentage) for nominal variables or in mean ± standard deviation for continuous variables. To evaluate accuracy of TTE guidance and TEE guidance, we did non-parametric Spearman's correlation analysis between defect size measured using echocardiography (TTE or TEE) and defect size measured using fluoroscopy. To compare between both guidance, we evaluated the differences in size measurement of TTE or TEE and size of fluoroscopy using Mann-Whitney test. We also evaluated performance of ASO procedure guided by TTE or TEE by comparing failure and complication rate of both groups. P value of less than 0.05 is considered significant statistically. All statistical analysis was done using SPSS 13.0 (SPSS Inc.) There was no significant difference in overall baseline characteristics between both groups (Table 1) . Mean age of patients undergoing ASO procedure was 25 ± 15 years; most (70%) were female.
RESULTS
From
There were also no difference in diameter measured by fluoroscopy and size of ASO used between both group. In overall ASO procedures, size of occluder devices used range from 12 to 38 mm (mean 26.1 ± 6.4 mm).
There was high correlation in diameter between TTE and fluoroscopy (r=0.837, p<0.001), and between TEE and fluoroscopy diameter (r=0.853, p<0.001). We found no significant difference in difference of size by echo and size by fluoroscopy between both TTE and TEE group (0.5 ± 3.8 and 2.0 ± 3.5, respectively, P=0.072). Fluoroscopy time in ASO procedures guided by TEE was longer compared to those guided by TTE, and the difference is statistically significant (33.2 ± 21.3 min vs. 22.8 ± 19.3 min, P=0.014). In group TEE, failure in implantation of devices occurred in 10 cases (16.1%), while in group TTE failure in 2 (9.1%) ( Table 2) , there is no significant difference (p=0.418). Atrial fibrillation occurred in one case in group TEE. This patient in fact has thyroid disease. Migration of devices occurred in 2 cases in TEE group. Total atrioventricular block occurred in 3 cases in TEE group and In 1 case in TTE group. In the case which total AV block occurred in the TTE group, the size of defect is also very large. In TEE group, immediate closure occurred in 50 cases (82%), complete closure from evaluation the next day in 94%), while in TTE group, immediate closure in 18 cases (90%), complete closure the next day in 100% cases. All patients were discharged the next day, aspirin were given for six months. 
DISCUSSION
Transcatheter closure of secundum atrial septal defects with ASO has been approved by FDA since December 2001. Since then this procedure has been performed in many centers, can be repositioned and retrieved prior to its release, and has a high rate of complete closure.
If performed in children, surgical closure of ASDs results in reduction of right ventricle volume overload and normalization of the size, 15 and similar results were also encountered if the defects were closed transcatheter with ASO. 16 TEE provides high accuracy in measuring the size of defects and assessing the type of defects, and also for showing the adequacy of the septal rims. A minimum of 5 mm of superior anterior rim is required for stable positioning of the device, while the aortic side rim is not mandatory due to the ability of the device to straddle the aorta. But TEE as guidance is uncomfortable for the patient, because it requires general anesthesia, may give limited views of the left atrium, and requires an additional expert operator 17 with additional cost.
In 22 patients in our study, we used TTE as guidance. The window used is transthoracal 4-chamber view visualizing atrial septal in vertical position. We are more familiar with this view as we used this daily in practice for diagnostic, and there is no limited views of the left atrium. There is no need for expert operator, and more cost effective. We can visualized clearly the introducer sheath loaded with ASO device entered left atrium from right atrium, then we can visualized when the left atrial side disc was deployed in the left atrium continued with deploying the right atrial disc in right atrium.
There were no significant differences in the characteristics between the 2 groups. Comparing the size diameter found between TTE and fluoroscopy, there were no difference, 23.3 ± 6.6 mm and 23.8 ± 6.6 mm respectively. Also between size diameter found by TEE and fluoroscopy, 21.0 ± 6.4 mm and 23.0 ± 6.3 mm respectively. We found no difference in accuracy of both echo guidance compare to fluoroscopy. These results reflects that TTE guidance have the same accuracy as TEE guidance, which have been used as routine procedures previously, and the fluoroscopy time in ASO procedures guided by TTE was shorter significantly compared to those guided by TEE. Sizes of devices chosen were equal or usually 2 mm larger than the sizes from balloon sizing. It is interesting to observe in our study that in TTE group, the size of devices chosen were close to both sizes measured by TTE and fluoroscopy, but in TEE group, the size of devices chosen were closer to size measured by fluoroscopy than by TEE. There was no significant difference between the failure of implantation between those two groups.
TTE guidance is still a new technique for ASO procedure, resulted in small sample size in TTE group compared to TEE group. It is, in fact, a goal of this study to motivate an increase in learning curve of TTE guidance for ASO procedure.
CONCLUSION
ASO procedures guided by TTE have similar accuracy to those guided by TEE, with shorter fluoroscopy time. TTE guidance also has no difference in failure rate compared to TEE guidance. TTE can be used safely and successfully as guidance in closing ASDs with ASO. This procedure is more friendly for the patients and relatively cost effective because general anesthesia is not required. Also more friendly for the users because the window used were more familiar.
